Urocortin, a new mammalian member of the corticotropin-releasing factor (CRF) family has been proposed to be the endogenous ligand for CRF receptor 2 (CRF-R2). We studied the influence of intravenous urocortin on gastric emptying and the role of CRF-R2 in peptide action and postoperative gastric ileus in conscious rats. The intravenous doses of rat CRF and rat urocortin producing 50% inhibition of gastric emptying were 2.5 and 1.1 µg/kg, respectively. At these intravenous doses, CRF and urocortin have their actions fully reversed by the CRF-R1/CRF-R2 antagonist astressin at antagonist/agonist ratios of 5:1 and 67:1, respectively. Astressin (12 µg/kg iv) completely prevented abdominal surgery-induced 54% inhibition of gastric emptying 3 h after surgery while having no effect on basal gastric emptying. The selective nonpeptide CRF-R1 antagonists antalarmin (20 mg/kg ip) and NBI-27914 (400 µg/kg iv) did not influence intravenous CRF-, urocortin- or surgery-induced gastric stasis. These results as well as earlier ones showing that -helical CRF₉₄₁ (a CRF-R2 more selective antagonist) partly prevented postoperative ileus indicate that peripheral CRF-R2 may be primarily involved in intravenous urocortin-, CRF-, and abdominal surgery-induced gastric stasis.

corticotropin-releasing factor; NBI-27914; antalarmin; astressin; postoperative gastric ileus; abdominal surgery

This article has been cited by other articles:

				T. Kimura, T. Amano, H. Uehara, H. Ariga, T. Ishida, A. Torii, H. Tajiri, K. Matsueda, and S. Yamato Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G903 - G910. [Abstract] [Full Text] [PDF]

				D. W. Adelson, H. P. Kosoyan, Y. Wang, J. Z. Steinberg, and Y. Tache Gastric Vagal Efferent Inhibition Evoked by Intravenous CRF Is Unrelated to Simultaneously Recorded Vagal Afferent Activity in Urethane-Anesthetized Rats J Neurophysiol, April 1, 2007; 97(4): 3004 - 3014. [Abstract] [Full Text] [PDF]

				C. Porcher, A. Juhem, A. Peinnequin, V. Sinniger, and B. Bonaz Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G1091 - G1103. [Abstract] [Full Text] [PDF]

				M. S. Mondal, Y. Date, N. Murakami, K. Toshinai, T. Shimbara, K. Kangawa, and M. Nakazato Neuromedin U acts in the central nervous system to inhibit gastric acid secretion via CRH system Am J Physiol Gastrointest Liver Physiol, June 1, 2003; 284(6): G963 - G969. [Abstract] [Full Text] [PDF]

				C Beglinger and L Degen Role of thyrotrophin releasing hormone and corticotrophin releasing factor in stress related alterations of gastrointestinal motor function Gut, July 1, 2002; 51(90001): i45 - 49. [Abstract] [Full Text]

				L. Wang, V. Martinez, J. E. Rivier, and Y. Tache Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2 Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1401 - R1410. [Abstract] [Full Text] [PDF]

				N. Kihara, M. Fujimura, I. Yamamoto, E. Itoh, A. Inui, and M. Fujimiya Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats Am J Physiol Gastrointest Liver Physiol, March 1, 2001; 280(3): G406 - G419. [Abstract] [Full Text] [PDF]

				V. Martínez, J. Rivier, and Y. Taché Peripheral Injection of a New Corticotropin-Releasing Factor (CRF) Antagonist, Astressin, Blocks Peripheral CRF- and Abdominal Surgery-Induced Delayed Gastric Emptying in Rats J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 629 - 634. [Abstract] [Full Text]

				M. Million, C. Maillot, P. Saunders, J. Rivier, W. Vale, and Y. Tache Human urocortin II, a new CRF-related peptide, displays selective CRF2-mediated action on gastric transit in rats Am J Physiol Gastrointest Liver Physiol, January 1, 2002; 282(1): G34 - G40. [Abstract] [Full Text] [PDF]